Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
Novartis announced the company’s financial results for the third quarter of 2019.
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.